11th Annual Advances in Heart Disease Prevention and Rehabilitation

Saturday, March 9, 2019, 7:15 AM - 3:15 PM EST, Troy Marriott, Ballroom

Recent studies have shown that arterial inflammation plays a key role in the development and progression of atherosclerosis, that acute myocardial infarctions often evolve from mild-to-moderate coronary artery stenoses, that patients who experience a fatal coronary event invariably had antecedent exposure to one or more major coronary risk factors (i.e., hypercholesterolemia, hypertension, cigarette smoking, diabetes, obesity), that angiographic findings may vastly underestimate underlying atherosclerotic coronary artery disease, and that aggressive medical management may represent a safe and effective alternative to many elective coronary revascularization procedures. Moreover, cardiorespiratory fitness appears to be one of the strongest prognostic markers in persons with and without heart disease. Collectively, these data highlight the value of lifestyle modification and contemporary pharmacotherapies in the prevention of initial and recurrent cardiovascular events. Several mechanisms may contribute to improved clinical outcomes, including partial (albeit small) anatomic regression of coronary artery stenoses, a reduced incidence of coronary inflammation, platelet aggregation, and plaque rupture, and enhanced coronary artery vasomotor function. Conference registrants will be provided the latest information on heart disease prevention and rehabilitation by a nationally distinguished faculty to “help patients help themselves.”

1. Describe the healthcare needs of an aging population, the importance of rebranding traditional cardiac rehabilitation programs, and the value in reaching out to families to facilitate these objectives.
2. Summarize the rationale for the changes made in the most recent American College of Cardiology/American Heart Association guidelines on the management of hypertension.
3. Assess the strengths and limitations of traditional atherosclerotic cardiovascular disease risk assessment and examine their impact on blood pressure management.
4. Describe the changes in creatine kinase and cardiac troponin that occur with vigorous exercise and their clinical significance.
5. Identify potential mechanisms by which high-volume, high-intensity exercise training may increase the risk of atrial fibrillation.
6. Review the inherited cardiac condition where habitual vigorous exercise appears to worsen prognosis.
7. Clarify the pathophysiology of lipoprotein (a), an emerging novel target for therapy, and review current and future approaches to treatment.
8. Review the individual and collective impact of increased physical activity, proper nutrition, weight management and avoidance of tobacco products, on lowering the risk of heart disease, diabetes and other chronic metabolic conditions, and the emerging field of “Lifestyle Medicine”.
9. Summarize the evidence supporting the role of selected physical, chemical, and psychological stressors in the triggering of acute cardiovascular events, as well as the potential role of various preventive interventions, including cardioprotective medications and regular moderate-to-vigorous intensity exercise training.
10. Review an interesting case study pertaining to a patient with cardiovascular disease (e.g., atherosclerotic coronary artery disease and/or structural abnormalities), including the diagnostic evaluations employed, the treatment approach used, and related cardiovascular outcomes.
11. Discuss the cardiac and non-cardiac benefits of daily aspirin and the management of patients on varied anticoagulation therapies.
12. Discuss the proximate cause of acute myocardial infarction, as well as the morphology, detection, and potential management of vulnerable coronary plaque.
13. Review the role of vitamin and mineral supplements for the primary and secondary prevention of cardiovascular disease, with specific reference to potential mechanisms of benefit and which supplements may be harmful.
14. Identify the role of evidence-based integrative medicine approaches in the prevention of chronic disease, and the fundamentals in guiding patients toward complementary mind/body techniques.
15. Explain the causes of sudden death in young athletes and the relative roles and efficacy of different screening strategies.
16. Identify the barriers and facilitators to adoption of healthy lifestyle behaviors in medically-supervised, home-based and worksite settings.

Register Here:

AMA PRA Category 1 Credits™ (5.75 hours), AMA PRA Non-Physician (Attendance) (5.75 hours)

Beaumont Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Beaumont Health designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Non-physician professionals should check with their individual credentialing bodies to confirm that participation in this CME activity will be approved for credit. CME credits can be used to meet the continuing education requirements needed for Michigan physician assistant and nursing relicensure without limitation. 

Saturday, March 9, 2019

Beaumont Health appreciates your interest in providing an exhibit/display for this event.  This event is accepting requests for exhibit/display space.  For more information about exhibit opportunities for this event, contact: Shannon Herrington, 248-898-1529, [email protected] Important Notice: Beaumont Health reserves the right to deny the request of service to any company that may be in conflict with the interests of our organization.